Drug Treatments for Osteoporosis

Follow the links below to find information about drug treatments for osteoporosis, and the effects of drugs on osteoporosis.

Updated January 2012

Printer friendly page Printer friendly page

29 Resources Found

Results 1 to 20 displayed.     1  2 

Title:   Hormones - cortisol
Publisher:   Better Health Channel
Description:   Cortisol is a hormone made by the adrenal glands. Conditions such as inflammatory disorders, skin disorders and some cancers can be treated with synthetic cortisol-like compounds, sometimes referred to as corticosteroids. A side effect of this treatment is osteoporosis. High doses of cortisol-like drugs over a long period of time can cause a drop in the body's own cortisol production.
Date:   Aug 2011
Title:   Lifestyle options
Publisher:   The Jean Hailes Foundation for Women's Health
Description:   Even when osteoporosis is diagnosed, lifestyle factors are still important in the management of this condition.
Date:   Jul 2011
Title:   Medical management
Publisher:   The Jean Hailes Foundation for Women's Health
Description:   Hormone therapy. Bisphosphonates. Evista (Raloxifene). Protos (Strontium ranelate). Potential therapies
Date:   Jul 2011
Title:   Breast cancer
Publisher:   The Jean Hailes Foundation for Women's Health
Description:   Women who develop breast cancer may be at risk of osteoporosis.
Date:   Jul 2011
Title:   Osteoporosis - prevention and treatment
Publisher:   Better Health Channel
Description:   Osteoporosis occurs when bones lose minerals such as calcium more quickly than the body can replace them. They become less dense, lose strength and break more easily. Calcium, exercise and vitamin D can help to prevent osteoporosis. If you have osteoporosis, medical treatment and lifestyle changes can prevent further bone loss.
Date:   Mar 2012
Title:   Use of antiresorptive agents for osteoporosis management
Publisher:   Australian Institute of Health and Welfare
Description:   There is no cure for osteoporosis but antiresorptive drugs can reduce further bone loss and slow down disease progression. This report provide information on both the individual and community use of antiresorptive drugs for managing osteoporosis as well as trends in the supply of and expenditure for these medications.
Date:   Jan 2011
Title:   Medication use for arthritis and osteoporosis
Publisher:   Australian Institute of Health and Welfare
Description:   Medicines are central to managing arthritis and osteoporosis, to improve musculoskeletal functions, slow disease progression and reduce pain and inflammation. Pharmaceutical innovations over the last several years have improved the efficacy and diversity of medicines available to manage these conditions.
Date:   Feb 2010
Title:   Osteoporosis self-care - myDr.com.au
Publisher:   myDr
Description:   Osteoporosis is when your bones become thinner and more likely to break. It affects more than 50% of women and about 30% of men over 60. Find out what products are available for osteoporosis.
Date:   Dec 2009
Title:   Bisphosphonates for osteoporosis in people with cystic fibrosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Cystic fibrosis is a serious genetic disorder that affects many organs (e.g. lung and pancreas). It commonly leads to reduced bone mineral density, known as osteoporosis, which increases the likelihood of fractures. The short-term and long-term effects ...
Date:   Feb 2012
Title:   Potential therapies
Publisher:   The Jean Hailes Foundation for Women's Health
Description:   Potential therapies - tibolone and parathyroid hormone
Date:   Jul 2009
Title:   Drug therapies
Publisher:   The Jean Hailes Foundation for Women's Health
Description:   Hormone therapy. Bisphosphonates. Raloxifene. Strontium ranelate
Date:   Jul 2009
Title:   Zoledronic acid (Aclasta) for osteoporosis
Publisher:   National Prescribing Service
Description:   Information for consumers about zoledronic acid (Aclasta), a new treatment for osteoporosis. This treatment is used only once a year, and is given through a drip into a vein.
Date:   Apr 2009
Title:   Have glitazones lost their sparkle?
Publisher:   Australian Prescriber
Description:   The thiazolidinediones, better known as 'glitazones', are under suspicion of causing serious, previously unsuspected adverse effects. Given these concerns, what can be said about the role of thiazolidinediones in third-line therapy of poorly controlled type 2 diabetes?
Date:   Jun 2008
Title:   Corticosteroid-induced osteoporosis and fractures
Publisher:   Australian Prescriber
Description:   Fragility fractures are a serious complication of long-term treatment with corticosteroids.The high frequency and rapid onset of corticosteroid-related fractures necessitates prompt identification of at-risk patients.
Date:   Apr 2008
Title:   Strontium ranelate (Protos) for osteoporosis in postmenopausal women
Publisher:   National Prescribing Service
Description:   Information for consumers about strontium ranelate (Protos) for osteoporosis in postmenopausal women.
Date:   Apr 2008
Title:   Alendronate (Fosamax) for osteoporosis - preventing fractures in people with very fragile bones (low bone mineral density)
Publisher:   National Prescribing Service
Description:   Information for consumers about the drug Alendronate for preventing fractures in people with very fragile bones (low bone mineral density) and osteoporosis.
Date:   Jan 2008
Title:   Alendronate for preventing fractures caused by osteoporosis in postmenopausal women
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   This summary of a Cochrane review presents what we know from research about the effect of alendronate for preventing fractures (broken bones) caused by osteoporosis. In women who have already been diagnosed with low bone density, putting them at risk f...
Date:   Nov 2007
Title:   Risedronate for preventing fractures caused by osteoporosis in postmenopausal women
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   This summary of a Cochrane review, presents what we know from research about the effect of Risedronate for preventing fractures (broken bones) caused by osteoporosis. In women who have already been diagnosed with low bone density putting them at risk f...
Date:   Nov 2007
Title:   Etidronate for preventing fractures caused by osteoporosis in postmenopausal women
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   This summary of a Cochrane review presents what we know from research about the effect of etidronate for preventing fractures (broken bones) caused by osteoporosis. In women who have already been diagnosed with low bone density, putting them at risk of...
Date:   Nov 2007
Title:   Bisphosphonate therapy for children and adolescents with secondary osteoporosis.
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   This summary of a Cochrane review presents what we know from research about the effect of bisphosphonates for osteoporosis in children and adolescents. The review shows that bisphosphonates: - may not lead to any difference in bone mineral density (bon...
Date:   Aug 2007

Results 1 to 20 displayed.     1  2